Still reflecting on the energy at the AI Leadership Symposium, organized by DigiTrends Arabia at the Pakistan Embassy, Riyadh.
Our session on AI for Patients – Physicians – Pharma brought together leaders actively shaping how AI delivers real value in healthcare.
Thank you to every attendee for curiosity, tough questions, and willingness to challenge conventional thinking. Shared commitment to collaboration made AI impactful.

#AIforHealthcare #AIforPharma #DigitalTransformation #DigiTrends

Will AI revolutionize drug development? Researchers explain why it depends on how it’s used
https://zurl.co/NvvFf
#ai #genai #aiforpharma #hls
Will AI revolutionize drug development? Researchers explain why it depends on how it’s used

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and effective drugs.

The Conversation
AI approach optimizes development of antibody drugs
https://zurl.co/ETZ7
#ai #genai #aiforpharma
AI approach optimizes development of antibody drugs

Proteins have evolved to excel at everything from contracting muscles to digesting food to recognizing viruses. To engineer better proteins, including antibodies, scientists often iteratively mutate the amino acids—the units that are arranged in a sequence to make up proteins—in different positions until the resulting protein has an improved function, like eliciting a stronger immune response or capturing carbon dioxide from the atmosphere more efficiently.

Phys.org
Generative AI Develops Drugs as Potential Treatment for Antibiotic-Resistant Bacteria
https://zurl.co/6mAK
#genai #ai #aiforpharma
Generative AI Develops Drugs as Potential Treatment for Antibiotic-Resistant Bacteria

Is Generative AI the solution for antibiotic-resistant bacteria?

Tech Times
With ‘Charlie,’ Pfizer is building a new generative AI platform for pharma marketing
https://zurl.co/Y3y2
#ai 3genai #aiforpharma #aiformarketing
With ‘Charlie,’ Pfizer is building a new generative AI platform for pharma marketing

Pfizer has developed its own generative AI platform called “Charlie,” named after Pfizer co-founder Charles Pfizer.

Digiday